Abstract:Cardiovascular disease (CVD) and metabolic syndrome (MetS) depends on sex, age and hormonal status and is worsened by comprised gut barrier function. Previous work establishes that loss of estrogen and age comprises intestinal barrier function permeability exacerbating systemic inflammation, increasing gut oxidative stress, and elevating pro-inflammatory cytokines. We hypothesize that loss of estrogen during menopause underlies sex- and age-dependent pathological remodeling in gut barrier function leading to increased risk for CVD and MetS. C57BL-6 male and female mice were fed a high-fat-diet (HFD, 45% fat); menopause was induced via 21 days of 4-vinylcycohexane diepoxide (VCD) intraperitoneal injections (controls were injected with sesame oil) in adult and aged female mice. Diestrus was reached 14+days after the end of VCD injections and menopause was determined by cytology. Upon sacrifice, plasma was collected, and intestines were flash frozen. LPS assays were performed on plasma samples of premenopausal (n=8), menopausal (n=10), aged menopausal (n=6), and male mice (n=11). Male mice, and aged menopausal mice had significantly higher circulating endotoxin levels than premenopausal mice, while menopausal mice did not significantly differ from pre-menopause. These results indicate that age and sex impact barrier leakiness. Further, these results highlight that barrier integrity in menopause is distinctly different from aged menopause mice.Quantitative proteomics of ileum samples in premenopausal (n=5), menopausal (n=5), aged menopausal (n=5), and male mice (n=5) identified 7664 proteins with >1 unique peptide of which 134 proteins were significant (p<0.05) with a max fold change ˂1.27 across all groups. Protein expression of all groups was assessed using principal component analysis. Aged menopausal mice cluster closer to premenopausal mice than menopausal mice. These results indicate that changes in the ileum during menopause are different than those observed in aging. Compared to premenopausal mice, menopausal mice have significantly increased in proteins involved in the Go-biological processes including an enrichment in proteins involved in the innate immune system (6.3 fold enrichment, FE, -log10p=0.00006), phagocytosis recognition (19.82 FE, -log10p=1.14), defense response to bacterium (10.066 FE, -log10p=9.56), and B cell receptor signaling pathways (20.311 FE, -log10p=9.33). In contrast, male mice compared to premenopausal mice show a significant decrease in proteins involved in phagocytosis recognition (22.57 FE, -log10p=4.28), defense response to bacterium (12.898 FE, -log10p=2.76), and B cell receptor signaling pathway (20.56 FE, -log10p=8.12). These results indicate an increase in immune activity in menopausal female mice and a decrease in male mice compared to premenopausal female mice. In summary, these data demonstrate the change within the gut during menopause is dissimilar to those seen in male and aging mice. This is the full abstract presented at the American Physiology Summit 2023 meeting and is only available in HTML format. There are no additional versions or additional content available for this abstract. Physiology was not involved in the peer review process.

Menopause Hormone Replacement Therapy and Lifestyle Factors affect Metabolism and Immune System in the Serum Proteome of Aging Individuals

Proteomics in aging research: A roadmap to clinical, translational research

Age, Sex, Body Mass Index, Diet and Menopause Related Metabolites in a Large Homogeneous Alpine Cohort

Common And Distinct Metabolomic Markers Related To Immune Aging In Western European And East African Populations

Effect of Menopausal Hormone Therapy on Cellular Immunity Parameters and Cytokine Profile

Demographic, Health and Lifestyle Factors Associated with the Metabolome in Older Women

Sex, age and menopause differentially impact gut barrier function and proteomic profile

Navigating the Proteomic Landscape of Menopause: A Review

Probing the impact of sex steroids and menopause-related sex steroid deprivation on modulation of immune senescence

Plasma Metabolic Profiles In Women Are Menopause Dependent

Undulating changes in human plasma proteome profiles across the lifespan

Age‐related metabolite profiles and their relation to clinical outcomes in young adults, middle‐aged individuals, and older people

The Influence of Metabolic Syndrome on Potential Aging Biomarkers in Participants with Metabolic Syndrome Compared to Healthy Controls

Plasma acylcarnitines and gut‐derived aromatic amino acids as sex‐specific hub metabolites of the human aging metabolome

The impact of reproductive factors on the metabolic profile of females from menarche to menopause

Cross-sectional and Longitudinal Relationship between Sex Hormones and Six Epigenetic Clocks in Older Adults: Results of the Berlin Aging Study II (BASE-II)

The effect of menopause on metabolic syndrome: cross-sectional results from the Canadian Longitudinal Study on Aging

Mendelian randomization identifies circulating proteins as biomarkers for age at menarche and age at natural menopause

Design and protocol of Estrogenic Regulation of Muscle Apoptosis (ERMA) study with 47 to 55-year-old women's cohort: novel results show menopause-related differences in blood count

Metabolite signatures of chronological age, aging, survival, and longevity

Transitions in metabolic and immune systems from pre-menopause to post-menopause: implications for age-associated neurodegenerative diseases